Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-9.09%
-10.00%
-4.13%
+6.16%
-1.92%
BNTX
BioNTech
$ 86.81
Strengths
Earnings are forecast to grow
Upgraded on attractively valued
Trading below its fair value
Risk Analysis
Analysts lowered price target
Chart
91.27
100.29
101.93
116.93
This Indicator assigning BNTX risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.
Risk Volatility
BNTX has Low Risk Level
Click here to check what is your level of risk
BNTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
Analysts lowered price target
BNTX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BNTX Street view is bullish and have positive views on the near-term outlook
BNTX Earnings
The TTM reflects 12-month period, providing review of BNTX financial performance.
NBIX
Neurocrine Biosciences
132.00
-0.41%
EXEL
Exelixis
22.52
+0.13%
AMGN
Amgen
268.93
+2.35%
Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses.
Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Most Trending
-9.09%
-10.00%
-4.13%
+6.16%
-1.92%
Stock Insights
Strengths
Earnings are forecast to grow
Upgraded on attractively valued
Trading below its fair value
Risk Analysis
Analysts lowered price target
BNTX Risk Level
The Indicator assigning BNTX risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.
Stock Analysis
BNTX
BioNTech
$ 86.81
BNTX Analysis
Chart
91.27
100.29
101.93
116.93
BNTX Analysts Opinion
BNTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
Analysts lowered price target
BNTX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BNTX Street view is bullish and have positive views on the near-term outlook
BNTX Earnings
The TTM data reflects the most recent 12-month period, providing overview of BNTX financial performance.
Score Tracker
Linked to BNTX
NBIX
Neurocrine Biosciences
-0.41%
132.00
EXEL
Exelixis
+0.13%
22.52
AMGN
Amgen
+2.35%
268.93
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
BNTX Stock trends
BNTX Stock performance
BNTX Stock analysis
BNTX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.